
Glorritus Pharmaceuticals Private Limited
About Glorritus Pharmaceuticals Private Limited
Data last updated:
Glorritus Pharmaceuticals Private Limited is a private limited company based in Kozhikode, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U33209KL2019PTC056158. Its GSTIN is 32AAHCG6181A1Z0 (Kerala).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Pulikkal Beljith (Managing Director) and Manoharan Ajith.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kozhikode, Kerala.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.89 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹5.57 Lakh (net margin 2.9%) and EBITDA of ₹8.67 Lakh (EBITDA margin 4.6%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 23% over five years.
As per MCA filings, the company has open charges of ₹40 Lakh on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it; 2 cases are pending.
Company details
Contact details
Glorritus Pharmaceuticals Private Limited's registered office is in Kozhikode, Kerala. Its e-mail address is in the company report.
- Email
- Registered Address65/3930 Jaya Building, Wayanad Road East Nadakkavu, Kozhikode, Kerala, India – 673006
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Glorritus Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Glorritus Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Glorritus Pharmaceuticals Private Limited, buy the company report.
Financials of Glorritus Pharmaceuticals Private Limited
FY 2025 filings availableGlorritus Pharmaceuticals Private Limited reported revenue of ₹1.89 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 7% growth in the latest year. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.67 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.57 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.6% | ||||
| Net Profit Margin | 2.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Glorritus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Glorritus Pharmaceuticals Private Limited
Glorritus Pharmaceuticals has 5 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoharan Ajith | Director | 10 Jan 2020 | 6 Years 10 Months | Current |
| Pulikkal Beljith | Managing Director | 10 Jan 2020 | 6 Years 10 Months | Current |
| Valiya Parambil Sunilkumar | Director | 02 Jan 2019 | 7 Years 10 Months | Current |
| Kuyil Veedu Chandran | Director | 02 Jan 2019 | 7 Years 10 Months | Current |
| Manilal Chandran Manaikudath | Director | 10 Jan 2020 | 6 Years 10 Months | Current |
Peer comparison
Glorritus Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| White Maple Pharmaceuticals Private Limited | ₹1.9 Cr (FY 2025) | -12.0% | Dibrugarh, Assam, India | |||
| Morksons Pharmaceuticals (India) Private Limited | ₹1.9 Cr (FY 2020) | -51.0% | New Delhi, Delhi, India | |||
| Zenkins Pharmaceuticals Private Limited | ₹1.9 Cr (FY 2025) | 29.0% | Ambala Cantt, Haryana, India | |||
| Morningg Life Pharmaceuticals Private Limited | ₹1.89 Cr (FY 2025) | 28.0% | Varanasi, Uttar Pradesh, India | |||
| Glorritus Pharmaceuticals Private Limitedthis company | ₹1.89 Cr (FY 2025) | ₹5.57 Lakh | 2.9% | 7.0% | Kozhikode, Kerala, India | |
| Shince Pharmaceuticals Private Limited | ₹1.89 Cr (FY 2025) | -7.0% | Chennai, Tamil Nadu, India | |||
| Pashupati Chemicals & Pharmaceuticals Limited | ₹1.87 Cr (FY 2024) | -23.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Glorritus Pharmaceuticals Private Limited, buy the company report.
Shareholding
The shareholding of Glorritus Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Glorritus Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Mar 2025 | 101084917 | Others | ₹40 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Glorritus Pharmaceuticals Private Limited has 3 court cases on record: 2 filed by Glorritus Pharmaceuticals, 1 filed against it. 2 cases are pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 1 |
| High courts | 1 | 1 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Court case (COMIP) | Filed against the company by Sun Pharmaceutical Industries Limited | Pending |
| District court, Kozhikode, Kerala | Criminal case | Filed by the company against Sims Hospital Shanthi Group of Instituion | Pending |
| District court, Kozhikode, Kerala | Criminal miscellaneous application | Filed by the company against Sims Hospital Shanthi Group of Instituion | Disposed |
To see the full case history of Glorritus Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Glorritus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Glorritus Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAHCG6181A1Z0 | Kerala | Active | 13 Mar 2019 |
To see the full GST registrations and return filing status of Glorritus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Glorritus Pharmaceuticals Private Limited has 5 board changes on record since 2019: 5 appointments. The latest: Manilal Chandran Manaikudath was appointed as Director on 10 Jan 2020.
Frequently asked questions
Glorritus Pharmaceuticals is an active private limited company based in Kozhikode, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 January 2019 (7+ years old) and is registered under CIN U33209KL2019PTC056158.
Glorritus Pharmaceuticals has 5 current directors:
- Pulikkal Beljith - Managing Director
- Manoharan Ajith - Director
- Valiya Parambil Sunilkumar - Director
- Kuyil Veedu Chandran - Director
- Manilal Chandran Manaikudath - Director
The latest financial statements of Glorritus Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Glorritus Pharmaceuticals is 32AAHCG6181A1Z0, registered in Kerala.
The CIN (Corporate Identification Number) of Glorritus Pharmaceuticals is U33209KL2019PTC056158. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Glorritus Pharmaceuticals has 3 court cases on record: 2 filed by the company and 1 filed against it. 2 are pending. Most are in the district courts.
Glorritus Pharmaceuticals was incorporated on 02 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Glorritus Pharmaceuticals by revenue are White Maple Pharmaceuticals Private Limited, Morksons Pharmaceuticals (India) Private Limited, Zenkins Pharmaceuticals Private Limited, Morningg Life Pharmaceuticals Private Limited, Shince Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Manilal Chandran Manaikudath was appointed as Director on 10 Jan 2020. Manoharan Ajith was appointed as Director on 10 Jan 2020. Pulikkal Beljith was appointed as Managing Director on 10 Jan 2020. Glorritus Pharmaceuticals has 5 board changes on record in total.
The registered office of Glorritus Pharmaceuticals is at 653930 Jaya Building, Wayanad Road East Nadakkavu, Kozhikode, Kerala, India – 673006.
Glorritus Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

